Impact of Busulfan Exposure on Transplant Outcomes for Patients with Relapsed Multiple Myeloma Undergoing CD34-Selected Allogeneic Hematopoietic Stem Cell Transplant

被引：0
|
作者：
Lin, Andrew [1 ]
Drill, Esther [2 ]
Proli, Anthony J. [1 ]
Beyer, Kristen [1 ]
Bhatt, Valkal [1 ]
Devlin, Sean M. [2 ]
Koehne, Guenther [3 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Pharm, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, 1275 York Ave, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Adult Bone Marrow Transplant Serv, Dept Med, 1275 York Ave, New York, NY 10021 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2017年 / 23卷 / 03期
关键词：
D O I：
10.1016/j.bbmt.2016.12.200
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
395
引用
收藏
页码：S288 / S289
页数：2
相关论文
共 50 条
  • [41] Allogeneic hematopoietic stem cell transplant after intravenous busulfan and fludarabine conditioning
    Kerbauy, Fabio R.
    Rodrigues, Morgani
    de Souza Santos, Fabio Pires
    Sobrinho, Jairo Nascimento
    Kutner, Jose Mauro
    Torres, Margareth A.
    Feitosa Ribeiro, Andreza Alice
    de Lima, Marcos
    Hamerschlak, Nelson
    LEUKEMIA & LYMPHOMA, 2011, 52 (02) : 321 - 324
  • [42] Autologous CD34-selected blood progenitor cell transplants for patients with advanced multiple myeloma
    Schiller, G
    Vescio, R
    Freytes, C
    Spitzer, G
    Lee, M
    Wu, CH
    Cao, J
    Lee, JC
    Lichtenstein, A
    Lill, M
    Berenson, R
    Berenson, J
    BONE MARROW TRANSPLANTATION, 1998, 21 (02) : 141 - 145
  • [43] An Observational Study on the Variability of Nutritional Status and Its Impact on Transplant Outcomes in Patients Undergoing Hematopoietic Stem Cell Transplant
    Gupta, Manasi
    Chaudhary, Vijay
    Pavitra, D. S.
    Joyal, Wesley
    Vats, Kashika
    Aggarwal, Himanshu
    Trivedi, Chirag
    John, M. Joseph
    BLOOD, 2024, 144 : 7288 - 7289
  • [44] Secondary malignancies in patients undergoing autologous hematopoietic cell transplant for multiple myeloma
    Sakellari, I.
    Mallouri, D.
    Bousiou, Z.
    Kaliou, M.
    Lalayanni, C.
    Papathanasiou, M.
    Constantinou, V.
    Papaioannou, G.
    Sotiropoulos, D.
    Batsis, I.
    Fytili, C.
    Geroukis, T.
    Katodritou, E.
    Vadikoliou, C.
    Anagnostopoulos, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S472 - S472
  • [45] Secondary Malignancies in Patients Undergoing Autologous Hematopoietic Cell Transplant for Multiple Myeloma
    Vadikoliou, Chrysanthi
    Bousiou, Zoi
    Kaliou, Maria
    Athanasiadou, Anastasia
    Sakellari, Ioanna
    Lalayanni, Chrysavgi
    Anagnostopoulos, Achilleas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E112 - E112
  • [46] Allogeneic stem cell transplant for multiple myeloma & myelofibrosis with split-dose busulfan, fludarabine & cyclophosphamide
    Trunk, Andrew D.
    Patel, Sagar S.
    Prchal, Josef T.
    Sborov, Douglas W.
    Zander, Axel R.
    Lee, Catherine J.
    LEUKEMIA RESEARCH REPORTS, 2023, 20
  • [47] Population Pharmacokinetic Model Demonstrates Poor Outcomes with ATG Overexposure in Adults Undergoing Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell
    Scordo, Michael
    Cho, Christina
    Devlin, Sean M.
    Maloy, Molly A.
    Ruiz, Josel D.
    Bhatt, Valkal
    Smith, Melody
    Shah, Gunjan L.
    O'Reilly, Richard J.
    Papadopoulos, Esperanza B.
    Jakubowski, Ann A.
    Tamari, Roni
    Perales, Miguel
    Giralt, Sergio A.
    Boelens, Jaap-Jan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S157 - S158
  • [48] Clofarabine Busulfan Conditioning Improves Outcomes in Patients with Active Acute Myelogenous Leukemia Undergoing Allogeneic Stem Cell Transplant
    Zebrowski, Alexis
    Hanlon, Alexandra
    Mangan, James
    Pinto-Martin, Jennifer
    Luger, Selina M.
    Loren, Alison W.
    Hexner, Elizabeth O.
    Reshef, Ran
    Gill, Saar I.
    Smith, Jacqueline
    Stadtmauer, Edward A.
    Porter, David
    Frey, Noelle V.
    BLOOD, 2014, 124 (21)
  • [49] Gonadal Function after Busulfan Compared with Treosulfan in Children and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplant
    Faraci, Maura
    Diesch, Tamara
    Labopin, Myriam
    Dalissier, Arnaud
    Lankester, Arian
    Gennery, Andrew
    Sundin, Mikael
    Uckan-Cetinkaya, Duygu
    Bierings, Marc
    Peters, Anke M. J.
    Garwer, Martina
    Schulz, Ansgar
    Michel, Gerard
    Giorgiani, Giovanna
    Gruhn, Bernd
    Locatelli, Franco
    Giardino, Stefano
    Uyttebroeck, Anne
    Rialland, Fanny
    Itala-Remes, Maija
    Dreger, Peter
    Shaw, Peter J.
    Bordon, Victoria
    Schlegel, Paul G.
    Mellgren, Karin
    Moraleda, Jose M.
    Patrick, Katharine
    Schneider, Pascale
    Jubert, Charlotte
    Lawitschka, Anita
    Salooja, Nina
    Basak, Grzegorz W.
    Corbacioglu, Selim
    Duarte, Rafael
    Bader, Peter
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (09) : 1786 - 1791
  • [50] Impact of Palifermin on Transplant Outcomes in Children and Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation
    Czyzewski, Krzysztof
    Debski, Robert
    Bartoszewicz, Natalia
    Demidowicz, Ewa
    Richert-Przygonska, Monika
    Lecka, Monika
    Tarasenko, Sonia
    Styczysnski, Jan
    ANTICANCER RESEARCH, 2020, 40 (11) : 6531 - 6537
12345